Testing Content Delivery Models for MomConnect

Status Recruiting

Clinical Trial Summary

The case for mobile health (mHealth) has been gaining traction as a source to improve health outcomes of individuals. mHealth refers to the use of Information and Communication Technologies (ICT) to support health care. The ubiquity and penetration of mobile phones presents the opportunity to deliver health care services directly to citizens, with the greatest potential gains in under-resourced health ecosystems. Operating for 8 years and currently supporting 1.28 million mothers through their pregnancies and early childhood care, MomConnect represents one of the largest maternal health messaging platforms in the world. Implemented at the national level, MomConnect has been credited with being the first national-scale mHealth program of its kind and has won numerous international awards. As a WhatsApp-delivered service, MomConnect has been limited by WhatsApp's historical terms of service. In its current form, MomConnect can only start a conversation with mothers once a week by alerting them of their upcoming antenatal care (ANC) appointment. Recent changes to WhatsApp's terms of service have removed the restriction around push messages for certain programs, including MomConnect. Messages have historically been restricted to weekly conversation starters and carry only generic administrative reminder-style information. As a result, it is possible that many mothers are failing to engage with the content as much as they could. If mothers were more engaged, it could greatly increase exposure and knowledge of reducing the total number of mothers exposed to critical maternal and infant health content. With the updated terms of service, there is an opportunity to test different ways of engaging mothers. This study proposes to evaluate, through a randomized controlled trial (RCT), the relative effect of three new behaviorally-informed program models on key knowledge of and adoption of healthy behaviors.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05505760
Study type	Interventional
Source	IDinsight
Contact	Philipp M Kastrau, PhD
Phone	+254746649552
Email	philipp.kastrau@idinsight.org
Status	Recruiting
Phase	N/A
Start date	May 30, 2023
Completion date	February 29, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00579605` - Motivational Interviewing to Promote Sustained Breastfeeding	N/A
Completed	`NCT05655364` - Development of a Breastfeeding Supportive Mobile Application	N/A
Completed	`NCT03853850` - Using Mobile Phone Text Messaging System to Improve Exclusive Breastfeeding Rate in a Resource-poor Caribbean Island	N/A
Completed	`NCT03957941` - FamilyLink and Breastfeeding	N/A
Withdrawn	`NCT03709004` - Pacifiers and Breastfeeding Among Mothers at Risk for Postpartum Depression	N/A
Completed	`NCT02958475` - Mother's Milk Messaging: Evaluation of a Bilingual Application (APP) to Support Initiation and Exclusive Breastfeeding in New Mothers	N/A
Active, not recruiting	`NCT05503069` - Community Interventions to Improve Breastfeeding	N/A
Not yet recruiting	`NCT02233439` - Double-blind, Placebocontrolled A Randomized Trial on the Efficacy of Herbal Galactogogues	N/A
Completed	`NCT01893736` - Professional Breastfeeding Support Intervention	N/A
Completed	`NCT02738957` - Effect of Prenatal Counseling on Breastfeeding Rates in Twins	N/A
Completed	`NCT00527956` - Facilitation and Barriers to Breastfeeding in the NICU	N/A
Completed	`NCT03655314` - Using the Electronic Health Record to Guide Management of Newborn Weight Loss	N/A
Completed	`NCT05562245` - Motivational Interviewing-Based Breastfeeding Education	N/A
Completed	`NCT05106634` - Evaluation of Breastfeeding Success and Self-Efficacy in Mothers Giving Birth Via Vaginal Delivery or Cesarean Section
Completed	`NCT05992753` - Mothers' Breast Milk Expression Experiences, Infant Feeding Attitudes and Perceived Social Support Levels
Recruiting	`NCT05213975` - Kinesio Taping Application After Cesarean Section	N/A
Recruiting	`NCT05250219` - Microchimeric Cell Tranfer From Mother to Child - Pilo Study
Recruiting	`NCT05371106` - Mycotoxins in Mothers Milk in Israel
Completed	`NCT03332108` - Novel Approach To Improving Lactation Support With Mobile Health Technology	N/A
Completed	`NCT02901665` - Impact of Increased Parent Presence in the Neonatal Intensive Care Unit on Parent & Infant Outcomes	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Testing Content Delivery Models for MomConnect — MQR

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms